Allspring Global Investments’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,349
Closed -$49.4K 1782
2024
Q3
$49.4K Buy
6,349
+406
+7% +$2.93K ﹤0.01% 1849
2024
Q2
$36K Sell
5,943
-1,440
-20% -$8.89K ﹤0.01% 2013
2024
Q1
$43.3K Sell
7,383
-79,772
-92% -$474K ﹤0.01% 1976
2023
Q4
$683K Buy
87,155
+5,295
+6% +$36.7K ﹤0.01% 1427
2023
Q3
$598K Sell
81,860
-121,896
-60% -$1.01M ﹤0.01% 1488
2023
Q2
$2.13M Buy
203,756
+10,536
+5% +$101K ﹤0.01% 1212
2023
Q1
$2M Buy
193,220
+69,357
+56% +$888K ﹤0.01% 1247
2022
Q4
$1.71M Sell
123,863
-42,782
-26% -$595K ﹤0.01% 1292
2022
Q3
$3.41M Buy
166,645
+1,560
+0.9% +$34.2K 0.01% 1083
2022
Q2
$3.19M Sell
165,085
-110,987
-40% -$2.27M 0.01% 1110
2022
Q1
$5.95M Sell
276,072
-162,431
-37% -$3.69M 0.01% 1071
2021
Q4
$12.1M Buy
+438,503
New +$12.1M 0.01% 868

Other funds holding ANGO

Allspring Global Investments's ANGO Position: Q4 2024 in Review

Allspring Global Investments sold out of AngioDynamics (ANGO) in Q4 2024, closing a stake of 6,349 shares — an estimated $49.4K sold.

Allspring Global Investments first reported a position in ANGO in Q4 2021 and held it in 12 quarters. The position peaked at $12.1M in Q4 2021. 135 funds tracked by Wall St. Rank hold ANGO as of Q4 2024.

  • Allspring Global Investments reported no remaining AngioDynamics position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 6,349 AngioDynamics shares in Q4 2024, an estimated $49.4K.
  • Allspring Global Investments first reported a position in AngioDynamics in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's AngioDynamics position peaked at $12.1M in Q4 2021.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.